- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1358579 [Title] => Liberia opens 2nd Ebola center in capital [Summary] =>Liberian authorities opened a new center to treat Ebola patients in the capital yesterday after the existing one became overwhelmed with patients, while two more airlines announced they will halt flights to the capitals of Liberia and Sierra Leone amid the deepening crisis.
[DatePublished] => 2014-08-17 06:18:34 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1413074 [AuthorName] => Jonathan Paye Layleh and Krista Larson [SectionName] => World [SectionUrl] => world [URL] => ) [1] => Array ( [ArticleID] => 1357886 [Title] => Liberia gets Ebola drug; ponders who should get it [Summary] =>Liberian officials faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.
[DatePublished] => 2014-08-15 01:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1413083 [AuthorName] => Jonathan Paye-Layleh and Sarah DiLorenzo [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
ASSISTANT HEALTH MINISTER TOLBERT NYENSWAH
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1358579 [Title] => Liberia opens 2nd Ebola center in capital [Summary] =>Liberian authorities opened a new center to treat Ebola patients in the capital yesterday after the existing one became overwhelmed with patients, while two more airlines announced they will halt flights to the capitals of Liberia and Sierra Leone amid the deepening crisis.
[DatePublished] => 2014-08-17 06:18:34 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1413074 [AuthorName] => Jonathan Paye Layleh and Krista Larson [SectionName] => World [SectionUrl] => world [URL] => ) [1] => Array ( [ArticleID] => 1357886 [Title] => Liberia gets Ebola drug; ponders who should get it [Summary] =>Liberian officials faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.
[DatePublished] => 2014-08-15 01:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1413083 [AuthorName] => Jonathan Paye-Layleh and Sarah DiLorenzo [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
EZ2 - 19 16
SUERTRES - 6 1 6
6/49 Lotto - 18 13 8 17 5 11
P25,062,058.00
6/58 Ultra Lotto - 45 37 56 7 35 24
P172,887,242.00
- 12:00 am